✨ Unlock Unlimited Data Exports & Disclosures Access with Tracenable Pro. Learn More →

Insulet Corp

Common Name
Insulet
Country
United States
Sector
Healthcare
Industry
Medical Devices
Employees
3,900
Ticker
PODD
Exchange
NASDAQ/NGS
Description
Insulet Corporation is a leading medical device company specializing in innovative insulin management systems for people with diabetes. Founded in 2000 and headquartered in Acton, Massachusetts, Insul...

Insulet's Financial Statements Preview

Below are the financial statements of Insulet, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in millions of USD
2024 as of 2024-12-31
2023 as of 2023-12-31
Assets
Current assets
Cash and cash equivalents
953.4a
704.2a
Accounts receivable trade, net
252.5a
240.2a
Accounts receivable trade, net - related party
113a
119.5a
Inventories
430.4a
402.6a
Prepaid expenses and other current assets
142a
116.4a
Total current assets
1,891.3a
1,582.9a
Property, plant and equipment, net
723.1a
664.9a
Other intangible assets, net
98.5a
98.7a
Goodwill
51.5a
51.7a
Deferred tax assets
141.8a
1.8a
Other assets
181.5a
188.2a
Total assets
3,087.7a
2,588.2a
Liabilities and stockholders’ equity
Current liabilities
Accounts payable
19.8a
19.2a
Accrued expenses and other current liabilities
423.8a
373.7a
Accrued expenses and other current liabilities - related party
1a
8.9a
Current portion of long-term debt
83.8a
49.4a
Total current liabilities
528.4a
451.2a
Long-term debt, net
1,296.1a
1,366.4a
Other liabilities
51.6a
37.9a
Total liabilities
1,876.1a
1,855.5a
Stockholders’ equity
Preferred stock
0a
0a
Common stock
0.1a
0.1a
Additional paid-in capital
1,184.4a
1,102.6a
Accumulated earnings (deficit)
40.3a
-378a
Accumulated other comprehensive (loss) income
-13.2a
8a
Total stockholders’ equity
1,211.6a
732.7a
Total liabilities and stockholders’ equity
3,087.7a
2,588.2a
Limited Data Preview
You are viewing a limited preview of Insulet’s balance sheet data. The reported financial values are complete. The full dataset, available for download, additionally includes structured metadata for each line item, such as line item role (line item, subtotal, total) and financial classification (e.g., assets, liabilities, equity, revenue, expenses).
Unrestricted Access to Data and Sources
pro
Remove manual data sourcing from your workflow. Upgrade to Tracenable Pro for unrestricted access to datasets and disclosures across 8,500+ companies with over 10 years of historical coverage.
Download complete datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace values back to original sources
Formats Included
Excel
CSV
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind Insulet’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Insulet’s data sources below and access millions more through our Disclosure Search.

a. Insulet's 10-K 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?